Survey: Patients', doctors' technology use views differ
About 40% of patients want their primary care doctors to have access to handheld...Read more on AuntMinnie.comRelated Reading: Breast ultrasound spots more cancers in dense breasts Curium to file NDA for generic form of DaTscan Clarius launches 2nd-generation pocket ultrasound GE Healthcare revenues rise in Q3 GE, Premier partner on one-stop breast cancer center
Shortened protocol identifies more cancers than ultrasound or mammography.
Diagnostic mammography is effective on its own for evaluating palpable breast...Read more on AuntMinnie.comRelated Reading: Ultrasound performance mixed in breast cancer survivors Deep-learning algorithm helps assess dense breasts Supplemental dense breast screening practices vary WISDOM breast cancer screening study now open to all Hey, Alexa -- Tell me about breast density
Invasiveness research is an essential step in breast cancer metastasis. The application of high-frequency ultrasound microbeam stimulation (HFUMS) offers a manner of determining the invasion potential of human breast cancer cells by eliciting the elevation of transient cytoplasmic calcium ions (Ca2+). The fluorescent index (FI), which is a composite parameter reflecting calcium elevations elicited by HFUMS, was shown to be higher in invasive breast cancer cells (MDA-MB-231) compared to weakly invasive breast cancer cells (MCF-7) using the low-intensity 50-MHz HFUMS. This novel finding shows significant difference from the ...
Conclusion: The proposed imaging method can provide accurate and localized estimation of VP in cancers non-invasively and cost-effectively. Significance: Accurate and non-invasive assessment of VP can have a significant impact on diagnosis, prognosis, and treatment of cancers.
Boguševičius A Abstract Background and objectives: With improved diagnostic means of early breast cancer, the percentage of cases with metastasis in axillary lymph nodes has decreased from 50%-75% to 15%-30%. Lymphadenectomy and sentinel lymph node biopsy are not treatment procedures, as they aim at axillary nodal staging in breast cancer. Being surgical interventions, they can lead to various complications. Therefore, recently much attention has been paid to the identification of non-invasive methods for axillary nodal staging. In many countries, ultrasound is a first-line method to evaluate axillary lym...
Young women with breast cancer often experience financial difficulties after...Read more on AuntMinnie.comRelated Reading: Ultrasound performance mixed in breast cancer survivors Supplemental dense breast screening practices vary 10-minute breast MRI scan beats DBT for invasive cancer Breast screening reduces race-related cancer disparities Most cysts found on breast ultrasound don't need biopsy
Nine unique patient and ultrasound features may enable breast imagers to distinguish...Read more on AuntMinnie.comRelated Reading: Ultrasound performance mixed in breast cancer survivors Handheld ultrasound edges out ABUS in patient surveys Most cysts found on breast ultrasound don't need biopsy AI helps characterize breast masses on ultrasound Elastography shows high reproducibility in breast lesions
Ultrasound diagnosis of axillary lymph nodes has the advantages of ease, convenience and low cost; however, most previous studies evaluated lymph node metastasis of the entire axilla rather than the association between the ultrasound features of a single lymph node and its pathology. This prospective study was performed to explore the ultrasound features of lymph nodes observed in bionic medium in vitro and to develop a lymph node-specific model for prediction of metastasis based on analysis of the association between the ultrasound features and pathology of each lymph node.
CONCLUSIONS: Preoperative ultrasonography is very accurate in the detecting of axillary LN metastases. Patients with primary tumour size ≥ 1 cm, with grade ≥ 2 no special type carcinomas (NST - no special type, also known as invasive ductal carcinoma) or multicentric lobular invasive cancer should undergo a more thorough ultrasound evaluation. PMID: 32116311 [PubMed - as supplied by publisher]